Company Description
Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring and liability management, and financial and valuation advisory services worldwide.
The company operates in three segments: Corporate Finance (CF), Financial Restructuring (FR), and Financial and Valuation Advisory (FVA).
The CF segment offers general financial advisory services; and advises public and private institutions, including financial sponsors on buy-side and sell-side M&A transactions, debt and equity financings in both the private and public markets, and other corporate finance transactions.
The FR segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions.
This segment also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; liability management transactions; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing.
The FVA segment provides valuation services to companies, debt and equity interests including illiquid investments, and other assets and liabilities; offers fairness opinions in connection with M&A and other transactions, solvency opinions in connection with corporate spin-offs and dividend recapitalizations, and other types of financial opinions; and provides dispute resolution services.
It serves corporations, financial sponsors, and government agencies. Houlihan Lokey, Inc. was incorporated in 1972 and is headquartered in Los Angeles, California.
| Country | United States |
| Founded | 1972 |
| IPO Date | Aug 13, 2015 |
| Industry | Capital Markets |
| Sector | Financials |
| Employees | 2,601 |
| CEO | Scott Adelson |
Contact Details
Address: 10250 Constellation Boulevard, 5th Floor Los Angeles, California 90067 United States | |
| Phone | 310 553 8871 |
| Website | hl.com |
Stock Details
| Ticker Symbol | HLI |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001302215 |
| CUSIP Number | 441593100 |
| ISIN Number | US4415931009 |
| Employer ID | 95-2770395 |
| SIC Code | 6282 |
Key Executives
| Name | Position |
|---|---|
| Scott Joseph Adelson | Chief Executive Officer and Director |
| Irwin N. Gold J.D. | Co-Chairman and Chairman of the Board |
| Scott Lee Beiser | Co-Chairman and Director |
| J. Lindsey Alley | MD and Chief Financial Officer |
| Todd John Carter Esq. | MD and Director |
| Paul Eric Siegert | Co-Chairman, Global Co-Head of Financial Restructuring and Director |
| Craig E. Tessimond | Managing Director |
| Nana Kyei | Managing Director of Technology Group |
| Jacques Cornet | Investor Relations Professional |
| Christopher M. Crain J.D. | MD, General Counsel and Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 19, 2025 | 144 | Filing |
| May 15, 2025 | 10-K | Annual Report |
| May 15, 2025 | SCHEDULE 13G/A | Filing |
| May 13, 2025 | 144 | Filing |
| May 8, 2025 | 8-K | Current Report |
| Apr 17, 2025 | SCHEDULE 13G/A | Filing |
| Apr 14, 2025 | 144 | Filing |
| Mar 13, 2025 | 144 | Filing |
| Feb 13, 2025 | 144 | Filing |
| Feb 4, 2025 | 10-Q | Quarterly Report |